2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon

Key Points A biotech upstart and a life sciences giant could be compelling additions to an investor's portfolio. NovoCure is a high-risk but potentially high-reward bet on industry-changing technology. Danaher has faced some headwinds to growth recently, but the core business remains profitable. 10 stocks we like better than NovoCure › If you have a 40-year time horizon for investing, putting some of your investment capital into healthcare stocks can enable you to take advantage of long-term tren ...